Status:

UNKNOWN

Validation of the Italian Version of the PRO-CTCAE

Lead Sponsor:

National Cancer Institute, Naples

Conditions:

Malignant Neoplasms

Eligibility:

All Genders

18+ years

Brief Summary

The aim of this study is to complete the validation process by testing the remaining two psychometric properties (validity and responsiveness) of the Italian version of the PRO-CTCAE in a large group ...

Detailed Description

This is a prospective observational study, conducted in Italian cancer centers located Nationwide. The investigators plan to consider for validation 21tumor sites, which correspond to the conditions ...

Eligibility Criteria

Inclusion

  • Diagnosis of any type of cancer
  • •≥18 years of age.
  • Female or male
  • With at least two planned clinic visits (a return visit within 3-6 weeks) to avoid the need of extra visits
  • Actively receiving treatment for cancer (going to receive the second or further cycle)
  • Any ECOG performance status (PS)
  • Able to complete questionnaire by themselves or with assistance, by using a tablet
  • Able to speak and understand Italian
  • Providing informed written consent

Exclusion

  • Having any kind of psychiatric disorder or major cognitive dysfunction hampering the provision of informed consent.
  • Having received more than 5lines of therapies
  • Currently participating in other trials which imply the completion of Patient Reported Outcomes (PROs) in the same period
  • Other important acute medical conditions.

Key Trial Info

Start Date :

July 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2024

Estimated Enrollment :

3675 Patients enrolled

Trial Details

Trial ID

NCT04416672

Start Date

July 1 2018

End Date

July 1 2024

Last Update

March 24 2023

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

Oncologia Medica per la Patologia Toracica- IRCCS Giovanni Paolo II

Bari, Italy

2

U.O.C. Oncologia Medica - Ospedale Senatore Antonio Perrino

Brindisi, Italy

3

Azienda Ospedaliero Universitaria di Cagliar

Cagliari, Italy

4

Oncologia Medica 2 - IRCCS AOU San Martino

Genova, Italy